TRCT
DSCI

Tower Research Capital (TRC)’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Tower Research Capital (TRC)’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-524
Closed -$3K – 4670
2016
Q4 		$3K Sell
524
-317
-38% -$1.49K ﹤0.01% 3371
2016
Q3 		$4K Buy
841
+513
+156% +$2.39K ﹤0.01% 2797
2016
Q2 		$1K Sell
328
-4,242
-93% -$15.9K ﹤0.01% 4365
2016
Q1 		$14K Buy
+4,570
New +$15.3K ﹤0.01% 1677
2015
Q4 		– Sell
-4,931
Closed -$23K – 5784
2015
Q3 		$23K Sell
4,931
-10,390
-68% -$67.1K ﹤0.01% 1634
2015
Q2 		$110K Buy
15,321
+14,188
+1,252% +$107K 0.01% 735
2015
Q1 		$10K Buy
1,133
+7
+0.6% +$60 ﹤0.01% 2844
2014
Q4 		$10K Sell
1,126
-3,976
-78% -$34.6K ﹤0.01% 2209
2014
Q3 		$43K Buy
+5,102
New +$47.3K ﹤0.01% 1671
2014
Q1 		– Sell
-1,748
Closed -$19K – 5594
2013
Q4 		$19K Sell
1,748
-1,847
-51% -$21.5K ﹤0.01% 2428
2013
Q3 		$44K Buy
3,595
+1,025
+40% +$14.2K ﹤0.01% 2037
2013
Q2 		$34K Buy
+2,570
New +$33K ﹤0.01% 1254

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Tower Research Capital (TRC)'s DSCI Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 524 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in DSCI in Q2 2013 and held it in 12 quarters. The position peaked at $110K in Q2 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 524 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $3K.
  • Tower Research Capital (TRC) first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Derma Sciences, Inc. Common Stock (DE) position peaked at $110K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.